Melani R Custodio1,2, Rosilene M Elias3,4, Wagner D Velasquez3, Luciene M Dos Reis3, Ivone B Oliveira3, Rosa M A Moysés3,4, Aluizio B Carvalho5, Vanda Jorgetti3. 1. Nephrology Division, Universidade de São Paulo, São Paulo, Brazil. melrcustodio@yahoo.com.br. 2. Serviço de Nefrologia, Faculdade de Medicina da Universidade de São Paulo, Rua Dr. Enéas de Carvalho Aguiar 255, 7° andar, São Paulo, SP, CEP 05403-000, Brazil. melrcustodio@yahoo.com.br. 3. Nephrology Division, Universidade de São Paulo, São Paulo, Brazil. 4. Medicine Master Degree Program, Universidade Nove de Julho, UNINOVE, São Paulo, Brazil. 5. Nephrology Division, Universidade Federal de São Paulo, São Paulo, Brazil.
Abstract
PURPOSE: Bone biopsy defines classical diseases that constitute the renal osteodystrophy. There is a recent concern regarding other histological findings that are not appreciated by using the turnover, mineralization, and volume (TMV) classification. Iron (Fe) overload has been considered a new challenge and the real significance of the presence of this metal in bones is not completely elucidated. Therefore, the main goal of the current study was to not only to identify bone Fe, but also correlate its presence with demographic, and biochemical characteristics. METHODS: This is a cross-sectional analysis of bone biopsies performed in 604 patients on dialysis from 2010 to 2014 in a tertiary academic Hospital. RESULTS: Histomorphometric findings revealed the presence of Fe in 29.1%. Fe was associated with higher levels of serum ferritin and serum calcium. No TMV status was related to Fe bone overload. CONCLUSION: Our study has highlighted that the presence of Fe in one-third of bone samples has unknown clinical significance. The lack of other contemporary bone biopsy study reporting Fe prevents us from comparison. The findings presented here should be specifically addressed in a future research and will require attention prior to implementation of any clinical guideline. If any proposed treatment, however, would change the bone Fe-related morbidity is undetermined.
PURPOSE: Bone biopsy defines classical diseases that constitute the renal osteodystrophy. There is a recent concern regarding other histological findings that are not appreciated by using the turnover, mineralization, and volume (TMV) classification. Iron (Fe) overload has been considered a new challenge and the real significance of the presence of this metal in bones is not completely elucidated. Therefore, the main goal of the current study was to not only to identify bone Fe, but also correlate its presence with demographic, and biochemical characteristics. METHODS: This is a cross-sectional analysis of bone biopsies performed in 604 patients on dialysis from 2010 to 2014 in a tertiary academic Hospital. RESULTS: Histomorphometric findings revealed the presence of Fe in 29.1%. Fe was associated with higher levels of serum ferritin and serum calcium. No TMV status was related to Fe bone overload. CONCLUSION: Our study has highlighted that the presence of Fe in one-third of bone samples has unknown clinical significance. The lack of other contemporary bone biopsy study reporting Fe prevents us from comparison. The findings presented here should be specifically addressed in a future research and will require attention prior to implementation of any clinical guideline. If any proposed treatment, however, would change the bone Fe-related morbidity is undetermined.
Entities:
Keywords:
Bone biopsy; Dialysis; Ferritin; Histomorphometry; Iron
Authors: Sonia M Holanda Almeida Araújo; Pablo Ambrosoni; Rosélia R Santos Lobão; Hena Caorsi; Rosa M A Moysés; Fellype Carvalho Barreto; Inés Olaizola; Elisa A S Cruz; Alicia Petraglia; Luciene M Dos Reis; Maria Eugênia Duarte; Vanda Jorgetti; Aluizio B Carvalho Journal: Kidney Int Suppl Date: 2003-06 Impact factor: 10.545
Authors: Luciene M Dos Reis; João R Batalha; Daniel R Muñoz; Aurélio Borelli; Pedro H S Correa; Aluizio B Carvalho; Vanda Jorgetti Journal: J Bone Miner Metab Date: 2007-10-25 Impact factor: 2.626
Authors: Aluizio Barbosa Carvalho; Ricardo Carneiro; Graziella M Leme; Carlos E Rochitte; Raul D Santos; Márcio H Miname; Rosa M Moyses; Vanda Jorgetti; Maria Eugênia F Canziani Journal: J Bone Miner Metab Date: 2013-03-21 Impact factor: 2.626
Authors: A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker Journal: J Bone Miner Res Date: 1987-12 Impact factor: 6.741
Authors: George R Bailie; Maria Larkina; David A Goodkin; Yun Li; Ronald L Pisoni; Brian Bieber; Nancy Mason; Lin Tong; Francesco Locatelli; Mark R Marshall; Masaki Inaba; Bruce M Robinson Journal: Nephrol Dial Transplant Date: 2013-10 Impact factor: 5.992
Authors: Jaime Tsay; Zheiwei Yang; F Patrick Ross; Susanna Cunningham-Rundles; Hong Lin; Rhima Coleman; Philipp Mayer-Kuckuk; Stephen B Doty; Robert W Grady; Patricia J Giardina; Adele L Boskey; Maria G Vogiatzi Journal: Blood Date: 2010-06-16 Impact factor: 22.113
Authors: Joel D Hernandez; Katherine Wesseling; Renata Pereira; Barbara Gales; Rick Harrison; Isidro B Salusky Journal: Clin J Am Soc Nephrol Date: 2008-11 Impact factor: 8.237
Authors: Edwin Patino; Stephen B Doty; Divya Bhatia; Kelly Meza; Yuan-Shan Zhu; Stefano Rivella; Mary E Choi; Oleh Akchurin Journal: Kidney Int Date: 2020-06-20 Impact factor: 10.612